Home » Stocks » DGX

Quest Diagnostics Incorporated (DGX)

Stock Price: $130.24 USD 0.81 (0.63%)
Updated Jun 22, 2021 4:00 PM EDT - Market closed
Market Cap 15.88B
Revenue (ttm) 10.34B
Net Income (ttm) 1.80B
Shares Out 133.00M
EPS (ttm) 13.18
PE Ratio 9.88
Forward PE 11.29
Dividend $2.30
Dividend Yield 1.77%
Trading Day June 22
Last Price $130.24
Previous Close $129.43
Change ($) 0.81
Change (%) 0.63%
Day's Open 129.57
Day's Range 129.51 - 130.88
Day's Volume 1,096,866
52-Week Range 101.78 - 142.80

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

SECAUCUS, N.J., June 21, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today released the Annual Corporate Responsibil...

1 day ago - PRNewsWire

When screening the market for high return investments amid non-cyclical stocks, investors may want to consider the three companies listed below, as their earnings yields (as calculated via Joel Greenbla...

Other stocks mentioned: AGRO, PRDO
4 days ago - GuruFocus

These companies dominate a vital medical industry niche, and their valuations are near their all-time lows.

Other stocks mentioned: LH
4 days ago - The Motley Fool

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today launched the EZH2Now...

Other stocks mentioned: EPZM
6 days ago - Business Wire

MedTech testing stocks like Quest Diagnostics Incorporated (DGX), Thermo Fisher Scientific, Inc. (TMO) and Laboratory Corporation of America Holdings (LH) are likely to survive post-pandemic.

Other stocks mentioned: ABT, LH, TMO
2 weeks ago - Zacks Investment Research

3 Medical Info System Stocks to Bank on Despite Decline in COVID-19 Cases

Other stocks mentioned: CERN, CNTG, CPSI
2 weeks ago - Zacks Investment Research

Mercy's outreach laboratory services are set to get integrated into Quest Diagnostics' (DGX) full-service laboratory in Lenexa, KS.

2 weeks ago - Zacks Investment Research

SECAUCUS, N.J. and ST. LOUIS, June 1, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX) and Mercy today announced that Quest has completed its previously announced acquisition of the outreach laboratory...

3 weeks ago - PRNewsWire

Quest Diagnostics' (DGX) new collaboration with SAHRC will help improve the health and quality of lives of underserved communities.

3 weeks ago - Zacks Investment Research

SECAUCUS, N.J., May 26, 2021 /PRNewswire/ -- The COVID-19 pandemic did not dampen workforce drug testing positivity for marijuana, which continued to increase last year in the general U.S. workforce, ac...

3 weeks ago - PRNewsWire

Like many other diagnostics and drug development companies, Laboratory Corp. of America Holdings ( LH , Financial) saw its base business decline as Covid-19 took hold. Fewer patients sought routine medi...

Other stocks mentioned: AMZN, LH, MTD, PKI
4 weeks ago - GuruFocus

3 Stocks to Bank on Rebounding Outpatient Home Health Industry

Other stocks mentioned: CHE, DVA, USPH
4 weeks ago - Zacks Investment Research

Contributions from acquisitions and Professional Lab Services relationships accelerate base business growth for Quest Diagnostics (DGX).

4 weeks ago - Zacks Investment Research

SECAUCUS, N.J. and NEW YORK, May 25, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX) and Paige today announced a collaboration designed to unlock the potential of artificial intelligence (AI) to impro...

4 weeks ago - PRNewsWire

SAN ANTONIO and SECAUCUS, N.J., May 24, 2021 /PRNewswire/ -- Childhood obesity has disproportionately affected Hispanic and Black communities as a result of negative social determinants of health for ye...

4 weeks ago - PRNewsWire

SECAUCUS, N.J., May 20, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarte...

1 month ago - PRNewsWire

SECAUCUS, N.J., May 19, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the J...

1 month ago - PRNewsWire

If you are looking for bargain opportunities among U.S.-listed equities, then you may want to consider the following three stocks, as they meet the criteria just listed below:

Other stocks mentioned: UMC, WHR
1 month ago - GuruFocus

This zero out-of-pocket option applies to Quest Diagnostics' (DGX) molecular laboratory (PCR/NAAT) as well as rapid antigen testing.

1 month ago - Zacks Investment Research

SECAUCUS, N.J., May 11, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today unveiled several new enhancements to its COVID-19 testi...

1 month ago - PRNewsWire

SECAUCUS, N.J., May 11, 2021 /PRNewswire/ --  A new Quest Diagnostics Health Trends® report developed in collaboration with the Centers for Disease Control and Prevention (CDC) found that the COVID-19 p...

1 month ago - PRNewsWire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--CIC Health and Quest Diagnostics announced a collaboration that will help more schools safely return to in-person learning.

1 month ago - Business Wire

BOSTON, May 3, 2021 /PRNewswire/ --  Ginkgo Bioworks ("Ginkgo") today announced a collaboration with Quest Diagnostics (NYSE:DGX) to provide COVID-19 Kindergarten through Senior (K-12) school testing se...

1 month ago - PRNewsWire

Want to have your cake and eat it, too? Here are 10 safe dividend stocks that have a strong history of boosting cash payouts to shareholders.

Other stocks mentioned: AAPL, AFL, ALL, BBY, CBOE, CL, KR ...
1 month ago - Kiplinger

SECAUCUS, N.J., April 27, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the...

1 month ago - PRNewsWire

The sector's Q1 results are likely to reflect solid earnings and revenue growth on strong base business recovery.

Other stocks mentioned: ABT, ALGN, BSX, HOLX, IART
1 month ago - Zacks Investment Research

The stock market is at all-time highs, and the world is starting to reopen. But these healthcare stocks have more growth opportunities ahead.

Other stocks mentioned: BNTX, GILD, MRK, REGN, TDOC, UHS
1 month ago - InvestorPlace

The updated first-half 2021 outlook by Quest Diagnostics (DGX) looks impressive given its raised revenue and operating cash flow expectations.

2 months ago - Zacks Investment Research

Quest Diagnostics (DGX) delivered earnings and revenue surprises of -0.27% and 1.29%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Shares of Quest Diagnostics (NYSE:DGX) rose 0.0% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 300.00% year over year to $3.76, which beat t...

2 months ago - Benzinga

SECAUCUS, N.J., April 22, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the firs...

2 months ago - PRNewsWire

Through the first quarter, Quest Diagnostics' (DGX) several significant strides in the field of COVID-19 diagnostic testing are expected to have contributed to the top line.

2 months ago - Zacks Investment Research

SECAUCUS, N.J. and HELSINKI, Finland, April 13, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Blueprint Genetics announced toda...

2 months ago - PRNewsWire

As of April 9, the GuruFocus All-in-One Screener, a Premium feature, found that the following companies have low price-earnings ratios and high dividend yields.

Other stocks mentioned: CE, CINF, STT, TSN
2 months ago - GuruFocus

SECAUCUS, N.J., April 7, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 202...

2 months ago - PRNewsWire

Quest Diagnostics (DGX) enters into an agreement with the CDC to provide genomic sequencing to identify new mutations in and patterns of transmission of SARS-CoV-2.

2 months ago - Zacks Investment Research

Quest Diagnostics' (DGX) divestment of Q2 solutions to IQVIA will allow IQVIA to lead Q2 Solutions on the next stage of its journey in central lab services as a global leader.

2 months ago - Zacks Investment Research

We have narrowed down our search to the following stocks, FLGT, BIO and IDXX based on a favorable Zacks Rank and strong prospects for 2021.

Other stocks mentioned: ABT, BDX, BIO, FLGT, IDXX
2 months ago - Zacks Investment Research

Quest Diagnostics Inc (NYSE: DGX) has announced selling the minority share in Q2 Solutions to IQVIA Holdings Inc (NYSE: IQV) for $760 million in cash. Q2 Solutions provides comprehensive testing, projec...

2 months ago - Benzinga

Investors are optimistic about Quest Diagnostics (DGX) owing to strong demand for COVID-19 testing and well-positioned growth strategy.

2 months ago - Zacks Investment Research

SECAUCUS, N.J. and RESEARCH TRIANGLE PARK, N.C.

Other stocks mentioned: IQV
2 months ago - PRNewsWire

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research ser...

Other stocks mentioned: IQV
2 months ago - Business Wire

MedTech stocks like INMD, BASI and SMLR are expected to maintain market-beating momentum in 2021.

Other stocks mentioned: BASI, HOLX, INMD, LH, RMD, SMLR
3 months ago - Zacks Investment Research

Value investors may be interested in the following three stocks since their share prices are trading below their respective Peter Lynch earnings lines, indicating they could be undervalued. Sell-side an...

Other stocks mentioned: COO, HOLX
3 months ago - GuruFocus

Quest Diagnostics (DGX) signs agreement with Zora to develop cardiovascular mortality prediction test with the help of the latter's patented ceramide-analysis technology.

3 months ago - Zacks Investment Research

SECAUCUS, N.J. and HELSINKI, March 15, 2021 /PRNewswire/ -- Zora Biosciences Oy, a clinical diagnostics company whose mission is to identify robust markers of disease and develop them into high-throughp...

3 months ago - PRNewsWire

According to the GuruFocus discounted cash flow calculator as of March 14, the following companies have a high margin of safety and have grown their margins over a 10-year period.

Other stocks mentioned: AZO, COO, GIB, LEN, LEN.B
3 months ago - GuruFocus

SECAUCUS, N.J., March 11, 2021 /PRNewswire/ -- At a virtual meeting with analysts and investors at its Investor Day, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), ...

3 months ago - PRNewsWire

SECAUCUS, N.J., and ST. LOUIS, March 8, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the leading provider of diagnostic information services, and Mercy, one of the nation's most highly integrated...

3 months ago - PRNewsWire

Davis Select Advisors recently released its fourth-quarter 2020 portfolio update. Among the changes made during the quarter, the firm disclosed a new position in Viatris Inc. (NASDAQ:VTRS), a position b...

Other stocks mentioned: CI, FB, GOOG, GOOGL, PFE, VTRS
3 months ago - GuruFocus

About DGX

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent ... [Read more...]

Industry
Diagnostics & Research
IPO Date
Dec 17, 1996
CEO
Stephen Rusckowski
Employees
50,000
Stock Exchange
NYSE
Ticker Symbol
DGX
Full Company Profile

Financial Performance

In 2020, DGX's revenue was $9.44 billion, an increase of 22.15% compared to the previous year's $7.73 billion. Earnings were $1.43 billion, an increase of 66.78%.

Financial Statements

Analyst Forecasts

According to 18 analysts, the average rating for DGX stock is "Buy." The 12-month stock price forecast is 145.21, which is an increase of 11.49% from the latest price.

Price Target
$145.21
(11.49% upside)
Analyst Consensus: Buy